Literature DB >> 19867234

EFFECT OF ACTINOMYCIN D ON RNA SYNTHESIS AND ANTIBODY FORMATION IN THE ANAMNESTIC RESPONSE IN VITRO.

J D Smiley1, J G Heard, M Ziff.   

Abstract

Antibody synthesis in anamnestic lymphoid cells, measured by incorporation of leucine-C(14) into specific antibody, was inhibited at moderate concentrations of actinomycin D. This was accompanied by marked inhibition of synthesis of RNA as measured by incorporation of H(3)-cytidine monophosphate. However, at low concentrations of actinomycin D, antibody synthesis was unaffected or even increased while RNA synthesis continued to be inhibited. The results obtained suggest that messenger RNA for antibody synthesis, either because it is relatively stable or present in excess, does not become a limiting factor until its synthesis is maximally inhibited. Puromycin, an inhibitor of amino acid coupling, abolished antibody synthesis in low concentration. 6-Mercaptopurine had no effect on the synthesis of antibody or RNA even at high concentration. The data obtained support the view that antibody synthesis follows pathways similar to those utilized for the formation of other types of proteins.

Entities:  

Year:  1964        PMID: 19867234      PMCID: PMC2137756          DOI: 10.1084/jem.119.6.881

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  The effect of 6-mercaptopurine on primary and secondary immune responses.

Authors:  R SCHWARTZ; A EISNER; W DAMESHEK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

3.  A study of antibody production in vitro.

Authors:  J H VAUGHAN; A H DUTTON; R W DUTTON; M GEORGE; R Q MARSTON
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

4.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

5.  The effect of 5-bromouracil deoxyriboside on the synthesis of antibody in vitro.

Authors:  R W DUTTON; A H DUTTON; J H VAUGHAN
Journal:  Biochem J       Date:  1960-05       Impact factor: 3.857

6.  THE CELLULAR SITES OF SYNTHESIS OF RIBOSOMAL AND 4S RNA.

Authors:  R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12       Impact factor: 11.205

7.  Sedimentation characteristics of rapidly labelled RNA from HeLa cells.

Authors:  K SCHERRER; J E DARNELL
Journal:  Biochem Biophys Res Commun       Date:  1962-06-04       Impact factor: 3.575

8.  Effect of actinomycin D on cellular nucleic acid synthesis and virus production.

Authors:  E REICH; R M FRANKLIN; A J SHATKIN; E L TATUM
Journal:  Science       Date:  1961-08-25       Impact factor: 47.728

9.  Autoradiographic studies on the immune response.I. The kinetics of plasma cell proliferation.

Authors:  G J NOSSAL; O MAKELA
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

10.  STUDIES ON ANTIBODY PRODUCTION : VII. THE EFFECT OF 5-BROMODEOXYURIDINE ON THE IN VITRO ANAMNESTIC ANTIBODY RESPONSE.

Authors:  T F O'Brien; A H Coons
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  4 in total

1.  IN VITRO SECONDARY 19S AND 7S ANTIBODY RESPONSES TO POLIOVIRUS IN MEMBRANE CULTURES OF SEPARATED SPLEEN CELLS.

Authors:  S E SVEHAG
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  Secondary response in vitro to antigen phi x 174 phage.

Authors:  M Pospísil; P Hájek
Journal:  Folia Microbiol (Praha)       Date:  1967       Impact factor: 2.099

3.  Antibody production in vitro. II. Effects of actinomycin D and puromycin on the secondary response to sheep erythrocytes.

Authors:  G Harris
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

4.  Regulation of the secondary antibody response in vitro. Enhancement by actinomycin D and inhibition by a macromolecular product of stimulated lymph node cultures.

Authors:  C T Ambrose
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.